FDA Issues Recall for Over 11,000 Bottles of Blood Pressure Medication
The United States Food and Drug Administration (FDA) has announced a recall of approximately 11,000 bottles of a blood pressure medication following a quality control issue identified during testing.
According to the FDA, the affected product is Chlorthalidone Tablets (25 mg), which is commonly used to treat high blood pressure and conditions involving excess fluid retention linked to heart, kidney, or liver disorders.
Reason for Recall
The recall was initiated after the medication failed to meet dissolution testing standards. This raised concerns that the drug may not deliver the intended level of effectiveness.
The product was manufactured by an India-based pharmaceutical company and distributed in the United States by a New Jersey-based pharmaceutical firm.
Details of Affected Products
The recall includes specific batches of the medication in 100-tablet and 1,000-tablet bottles. In total, around 11,460 bottles are affected. The products have an expiration date of April 2027.
Guidance for Patients
Health authorities have advised patients to check their medication packaging and compare it with the recall details. Individuals who find that they possess the affected product are encouraged to consult their pharmacist or healthcare provider before making any changes to their treatment.
Patients are strongly advised not to discontinue prescribed medication without medical guidance.
Ongoing Evaluation
The FDA has stated that it is still assessing the potential health risk associated with the recalled medication. Further updates are expected as the investigation continues.
